Summit Therapeutics PLC (SMMT) stock news · $11.46B cap
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
This SMMT news page leads with what Summit Therapeutics PLC filed — not a scraped headline mill.
No cached 8-K sentence for SMMT yet. We will not pad this page with generic market recap.
Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SMMT stock page; for the tape open the quote page.
SMMT stock news FAQ
What is SMMT's latest net income?
Latest cached Summit Therapeutics PLC (SMMT) net income was -$221.3M. Statements: https://lician.com/financials/smmt
What is SMMT's market cap?
Summit Therapeutics PLC (SMMT) market cap is $11.46B on the latest cached fundamentals snapshot.
What kind of company is SMMT?
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Where is SMMT stock news listed?
Cached stock news for Summit Therapeutics PLC (SMMT) is listed at https://lician.com/news/smmt. Filings: https://lician.com/sec/smmt
Not investment advice.